Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 08 - 01 tags : Drug save search
STELARA® (ustekinumab) Approved by the U.S. Food and Drug Administration to Treat Pediatric Patients with Active Psoriatic Arthritis
Published: 2022-08-01 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
stelara drug active approved food
Novel Carbohydrate Antiviral Drug Candidate Acts Through Galectin Inhibition to Block SARS-CoV-2 Coronavirus
Published: 2022-08-01 (Crawled : 17:00) - biospace.com/
BIXT A | $0.146 490.75% 120K
|
Professional, Scientific, and T...
|
| O: 16.64%
H: 0.0%
C: -18.33%
drug candidate antiviral sars-cov-2
RxSpark Partners with Marley Drug to Integrate Mail Order Pharmacy to its Next Generation Discounts Program
Published: 2022-08-01 (Crawled : 15:00) - prnewswire.com
MCUJF | $0.6797 0% 130
|
Health Technology
|
| O: -1.0%
H: 0.0%
C: 0.0%
drug order program
SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug Application for BREXAFEMME®
Published: 2022-08-01 (Crawled : 13:00) - biospace.com/
SCYX | $1.495 -3.55% -3.68% 88K
|
Health Technology
|
| O: -0.43%
H: 6.09%
C: 5.22%
brexafemme drug application review food
Rubedo Life Sciences Expands Leadership Team with Ali Siam as Chief Business Officer and Ofir Moreno, Ph.D., as SVP of Drug Discovery
Published: 2022-08-01 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
sciences drug life
SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug Application for BREXAFEMME® (ibrexafungerp tablets) for Prevention of Recurrent Vaginal Yeast Infections
Published: 2022-08-01 (Crawled : 13:00) - globenewswire.com
SCYX | $1.495 -3.55% -3.68% 88K
|
Health Technology
|
| O: -0.43%
H: 6.09%
C: 5.22%
brexafemme drug application infections review food
Pharmaceutical Excipients Market Players Focus on Development of Next-gen Drug Delivery Systems, States TMR Study
Published: 2022-08-01 (Crawled : 12:00) - prnewswire.com
DD | News | $73.96 0.22% 0.0% 1.5M
|
Process Industries
|
| O: -1.27%
H: 0.23%
C: -0.41%
drug study market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.